Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Scientists discover why bread can cause weight gain without extra calories
- The dirtiest thing in public bathrooms isn’t the toilet seat
- Men and women with obesity face very different hidden health risks
- Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology
- Scientists discover spice synergy that boosts anti-inflammation 100x
- Scientists discover why flu and COVID hit older adults so hard
- This common vaccine cuts heart risk nearly in half in new study
- The surprising cancer link between cats and humans
- He survived 48 hours without lungs and lived
- DNA origami vaccines could be the next leap beyond mRNA
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
